We are live on
!
Find out more
AAP
Arax Advisory Partners Portfolio holdings
AUM
$3.54B
1-Year Est. Return
19.14%
This Fund
S&P 500
This Quarter
Est. Return
+8.62%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
–
AUM
$6.97B
AUM Growth
+$4.79B
(+220%)
Cap. Flow
+$6.91B
Cap. Flow
% of AUM
99.25%
Top 10 Holdings %
Top 10 Hldgs %
36.51%
Holding
4,400
New
1,371
Increased
1,984
Reduced
143
Closed
794
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 100 ETF
OEF
|
+$2.43B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.24B |
| 3 |
DFAI
Dimensional International Core Equity Market ETF
DFAI
|
+$202M |
| 4 |
American Century Diversified Corporate Bond ETF
KORP
|
+$152M |
| 5 |
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Growth ETF
VUG
|
+$91.2M |
| 2 |
Vanguard Morningstar Value ETF
VTV
|
+$62.6M |
| 3 |
AXON
Axon Enterprise
AXON
|
+$58.1M |
| 4 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$46.5M |
| 5 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$44.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.48% |
| 2 | Financials | 8.05% |
| 3 | Industrials | 7.03% |
| 4 | Consumer Discretionary | 6.62% |
| 5 | Healthcare | 6.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CMBT
3176
CMB.TECH NV
CMBT
$4.62B
| $1.44K | ﹤0.01% |
+153
| New | +$1.4K |
|
3177
STRATTEC Security
STRT
$372M
| $1.43K | ﹤0.01% |
+21
| New | +$1.41K |
|
3178
PLAYSTUDIOS Inc
MYPS
$95.1M
| $1.43K | ﹤0.01% |
+1,483
| New | +$1.6K |
|
3179
Immunome
IMNM
$2.89B
| $1.41K | ﹤0.01% |
+120
| New | +$1.19K |
|
|
HSAI
3180
Hesai Group
HSAI
$2.81B
| $1.41K | ﹤0.01% |
+50
| New | +$1.22K |
|
|
EEX
3181
DELISTED
Emerald Holding
EEX
| $1.4K | ﹤0.01% |
+275
| New | +$1.39K |
|
3182
SR Bancorp
SRBK
$145M
| $1.39K | ﹤0.01% |
+92
| New | +$1.34K |
|
3183
Ginkgo Bioworks
DNA
$612M
| $1.39K | ﹤0.01% |
+95
| New | +$1.14K |
|
|
ORKA
3184
Oruka Therapeutics
ORKA
$5.86B
| $1.39K | ﹤0.01% |
+72
| New | +$1.07K |
|
3185
Kingstone Companies
KINS
$294M
| $1.38K | ﹤0.01% |
+94
| New | +$1.38K |
|
|
CMPS
3186
Compass Pathways
CMPS
$1.83B
| $1.38K | ﹤0.01% |
240
| – | – |
|
3187
Bausch + Lomb
BLCO
$5.99B
| $1.36K | ﹤0.01% |
+90
| New | +$1.3K |
|
3188
Telos
TLS
$350M
| $1.35K | ﹤0.01% |
+198
| New | +$946 |
|
3189
Replimune Group
REPL
$994M
| $1.35K | ﹤0.01% |
+323
| New | +$2.06K |
|
3190
Satellogic
SATL
$715M
| $1.35K | ﹤0.01% |
+412
| New | +$1.45K |
|
3191
Agilon Health
AGL
$1.8B
| $1.34K | ﹤0.01% |
+52
| New | +$1.96K |
|
|
JBIO
3192
Jade Biosciences
JBIO
$1.32B
| $1.34K | ﹤0.01% |
155
+152
| +5,067% | +$1.24K |
|
3193
Capricor Therapeutics
CAPR
$228M
| $1.31K | ﹤0.01% |
+182
| New | +$1.34K |
|
|
CRON
3194
Cronos Group
CRON
$1.02B
| $1.31K | ﹤0.01% |
470
+210
| +81% | +$494 |
|
|
MPX
3195
DELISTED
Marine Products Corp
MPX
| $1.3K | ﹤0.01% |
+147
| New | +$1.31K |
|
3196
Savara
SVRA
$1.13B
| $1.3K | ﹤0.01% |
+363
| New | +$1.07K |
|
|
FLNA
3197
Filana Therapeutics
FLNA
$46.4M
| $1.29K | ﹤0.01% |
445
| – | – |
|
3198
Sociedad Química y Minera de Chile
SQM
$20B
| $1.29K | ﹤0.01% |
30
| – | – |
|
3199
ARS Pharmaceuticals
SPRY
$532M
| $1.29K | ﹤0.01% |
+128
| New | +$1.84K |
|
3200
Red Cat Holdings
RCAT
$1.32B
| $1.28K | ﹤0.01% |
+124
| New | +$1.16K |
|
Similar funds
TYCC
TH
BCP
WWA
VPC
BPS
TCM
DILIC
Arax Advisory Partners's Q3 2025 Portfolio in Review
As of Q3 2025, Arax Advisory Partners held 4,400 positions worth $6.97B, up 220% from $2.18B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Arax Advisory Partners deployed $6.91B of net new capital in Q3 2025, opening 1,371 new positions and adding to 1,984 existing holdings. Its largest new stake was American Century Diversified Corporate Bond ETF: 3,224,236 shares worth $194M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 6.5% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Axon Enterprise, an estimated $58.1M trimmed.
- Arax Advisory Partners's largest Q3 2025 buy was American Century Diversified Corporate Bond ETF: 3,224,236 shares worth $194M.
- Arax Advisory Partners added most to iShares S&P 100 ETF in Q3 2025, an estimated $2.43B increase.
- Arax Advisory Partners's biggest Q3 2025 reduction was Axon Enterprise, cutting an estimated $58.1M.
- Arax Advisory Partners fully exited Vanguard Morningstar Growth ETF in Q3 2025, selling an estimated $91.2M.
- Arax Advisory Partners's ten largest holdings make up 37% of its $6.97B portfolio in Q3 2025.
- Arax Advisory Partners opened 1,371 new positions and closed 794 in Q3 2025.
- Arax Advisory Partners's portfolio value rose 220% quarter-over-quarter to $6.97B.
Based on Arax Advisory Partners's 13F filing for Q3 2025, filed 14 Nov 2025.